The Contextual Genomics FIND IT® Cancer Hotspot Panel is a multiplex next generation sequencing assay, designed to identify common, clinically actionable genomic alterations in most solid tumour samples. The FIND IT panel provides a personalised understanding of a patient's tumour.
Why choose the FIND IT Cancer Hotspot Panel?
Detects mutations that have prognostic and diagnostic value.
Identifies potential therapeutics or potential clinical trials.
Finds acquired resistance mutations to drugs and assists in the selection of medicines.
Available exclusively through Sonic Genetics.
Detects single base substitutions (SNVs), small deletions and insertions up to 24 nucleotides.
Simultaneously evaluates the mutation status of tumour DNA at more than 120 well-characterised positions (hotspots) and 17 exons in 33 cancer-associated genes.
Catalogues genomic alterations, linking them to details on treatment sensitivity and resistance, as well as clinical trial information.
Reports feature a detailed clinical interpretation, with information based on the mutation profile of the tumour.
A seamless full service approach enables physicians to make more informed patient decisions.
Is the FIND IT test reimbursed by Medicare?
Currently the full FIND IT panel is not covered by a Medicare rebate and will be privately billed to the patient. Focused panels are available for the relevant Medicare rebate fee for eligible patients, avoiding any out-of-pocket charges. An add-on panel can be requested to extend a focused panel to a full panel. For current pricing, please see the 'FIND IT Information for Medical Specialists' and 'FIND IT Doctor Brief' publications available for download below. Please contact us if you have further enquiries.